KB LAMINATES
01888
CHINA CINDA
01359
CHINAHONGQIAO
01378
DONGFENG GROUP
00489
U-PRESID CHINA
00220
HK Stock MarketDetailed Quotes
02563 BIOSTAR PHARM-B
- 31.550
- -1.200-3.66%
Market Closed Dec 27 16:08 CST
11.50BMarket Cap-63.87P/E (TTM)
32.750High31.550Low341.20KVolume32.750Open32.750Pre Close10.91MTurnover0.16%Turnover RatioLossP/E (Static)364.59MShares39.50052wk High15.60P/B6.84BFloat Cap19.48052wk Low--Dividend TTM216.72MShs Float39.500Historical High--Dividend LFY3.66%Amplitude19.480Historical Low31.969Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
BIOSTAR PHARM-B Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|
| Cash flow from operating activities | ||||
| Earning before tax | -18.15%-189.64M | -64.47%-130.19M | ---160.51M | ---79.16M |
| Profit adjustment | ||||
| Interest (income) - adjustment | -310.39%-11.69M | -687.79%-10.32M | ---2.85M | ---1.31M |
| Investment loss (gain) | 16.14%-9.1M | 33.33%-8.52M | ---10.85M | ---12.78M |
| Impairment and provisions: | -142.20%-511K | -183.23%-561K | --1.21M | --674K |
| -Impairmen of inventory (reversal) | --773K | --718K | ---- | ---- |
| -Impairment of trade receivables (reversal) | -206.03%-1.28M | -289.76%-1.28M | --1.21M | --674K |
| Depreciation and amortization: | 1.14%10.62M | 3.30%8.05M | --10.5M | --7.79M |
| -Amortization of intangible assets | 2.47%1.21M | 3.31%904K | --1.18M | --875K |
| Financial expense | -19.72%57K | -2.08%47K | --71K | --48K |
| Exchange Loss (gain) | 76.27%-4.65M | 72.77%-6.56M | ---19.6M | ---24.11M |
| Special items | -45.00%44.4M | -34.99%36.33M | --80.74M | --55.88M |
| Operating profit before the change of operating capital | -58.47%-160.51M | -110.96%-111.74M | ---101.29M | ---52.97M |
| Change of operating capital | ||||
| Inventory (increase) decrease | 136.35%3.07M | 154.97%3.56M | ---8.44M | ---6.47M |
| Accounts receivable (increase)decrease | 465.42%25.22M | 247.47%19.62M | ---6.9M | ---13.3M |
| Accounts payable increase (decrease) | -88.01%3.39M | -132.80%-3.76M | --28.23M | --11.47M |
| prepayments (increase)decrease | -2,532.94%-8.95M | -7.05%-6.91M | ---340K | ---6.46M |
| Cash from business operations | -55.27%-137.79M | -46.51%-99.23M | ---88.74M | ---67.73M |
| Special items of business | -224.06%-11.54M | -223.65%-11.46M | --9.3M | --9.27M |
| Net cash from operations | -87.99%-149.33M | -89.34%-110.69M | ---79.44M | ---58.46M |
| Cash flow from investment activities | ||||
| Decrease in deposits (increase) | 71.97%-60.81M | 67.78%-64.85M | ---216.92M | ---201.29M |
| Purchase of fixed assets | 12.62%-27.84M | -26.26%-25.33M | ---31.86M | ---20.06M |
| Purchase of intangible assets | ---- | ---- | ---817K | ---757K |
| Recovery of cash from investments | -8.09%753.48M | -2.66%499.64M | --819.81M | --513.32M |
| Cash on investment | 25.38%-535M | 39.26%-280M | ---717M | ---461M |
| Net cash from investment operations | 188.45%129.83M | 176.24%129.46M | ---146.79M | ---169.8M |
| Net cash before financing | 91.38%-19.5M | 108.22%18.76M | ---226.23M | ---228.26M |
| Cash flow from financing activities | ||||
| New borrowing | ---- | ---- | --70K | --70K |
| Refund | ---68K | ---68K | ---- | ---- |
| Interest paid - financing | 19.72%-57K | 2.08%-47K | ---71K | ---48K |
| Other items of the financing business | ---- | ---- | --4.66M | --4.66M |
| Net cash from financing operations | -131.98%-1.13M | -124.35%-964K | --3.53M | --3.96M |
| Effect of rate | -109.64%-1.39M | -93.03%865K | --14.38M | --12.41M |
| Net Cash | 90.73%-20.63M | 107.94%17.8M | ---222.69M | ---224.3M |
| Begining period cash | -77.61%60.11M | -77.61%60.11M | --268.42M | --268.42M |
| Cash at the end | -36.63%38.09M | 39.37%78.77M | --60.11M | --56.52M |
| Cash balance analysis | ||||
| Currency Unit | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Trending HK Stocks
HK Dividend Stocks HK Dividend Stocks
Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.
